BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen Z, Jiang Z, Zhang W, He B. Silencing the expression of copine-III enhances the sensitivity of hepatocellular carcinoma cells to the molecular targeted agent sorafenib. Cancer Manag Res 2018;10:3057-67. [PMID: 30214300 DOI: 10.2147/CMAR.S167781] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 El-Huneidi W, Anjum S, Mohammed AK, Unnikannan H, Saeed R, Bajbouj K, Abu-Gharbieh E, Taneera J. Copine 3 "CPNE3" is a novel regulator for insulin secretion and glucose uptake in pancreatic β-cells. Sci Rep 2021;11:20692. [PMID: 34667273 DOI: 10.1038/s41598-021-00255-0] [Reference Citation Analysis]
2 Tang H, Pang P, Qin Z, Zhao Z, Wu Q, Song S, Li F. The CPNE Family and Their Role in Cancers. Front Genet 2021;12:689097. [PMID: 34367247 DOI: 10.3389/fgene.2021.689097] [Reference Citation Analysis]
3 Cheng CC, Chao WT, Liao CC, Shih JH, Lai YS, Hsu YH, Liu YH. The Roles Of Angiogenesis And Cancer Stem Cells In Sorafenib Drug Resistance In Hepatocellular Carcinoma. Onco Targets Ther 2019;12:8217-27. [PMID: 31632072 DOI: 10.2147/OTT.S217468] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
4 Rimassa L, Pressiani T, Merle P. Systemic Treatment Options in Hepatocellular Carcinoma. Liver Cancer. 2019;8:427-446. [PMID: 31799201 DOI: 10.1159/000499765] [Cited by in Crossref: 33] [Cited by in F6Publishing: 40] [Article Influence: 11.0] [Reference Citation Analysis]
5 Wang Y, Zhao M, Zhao H, Cheng S, Bai R, Song M. MicroRNA-940 restricts the expression of metastasis-associated gene MACC1 and enhances the antitumor effect of Anlotinib on colorectal cancer. Onco Targets Ther 2019;12:2809-22. [PMID: 31114229 DOI: 10.2147/OTT.S195364] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
6 Meng D, Lei M, Han Y, Zhao D, Zhang X, Yang Y, Liu R. MicroRNA-645 targets urokinase plasminogen activator and decreases the invasive growth of MDA-MB-231 triple-negative breast cancer cells. Onco Targets Ther 2018;11:7733-43. [PMID: 30464522 DOI: 10.2147/OTT.S187221] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]